OPen Label Study to Evaluate Long Term Treatment Effect of DiaPep277

NCT01460251 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: DiaPep277

Sponsor

Rabin Medical Center